TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated DiseasesBusiness Wire • 01/09/23
DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/04/23
BlackRock, Kimberly-Clark Among 13 Companies To Start 2023 With Annual Dividend IncreasesSeeking Alpha • 01/02/23
The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly StockInvestors Business Daily • 12/28/22